Literature DB >> 23149426

Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.

Robert H Schneider1, Clarence E Grim, Maxwell V Rainforth, Theodore Kotchen, Sanford I Nidich, Carolyn Gaylord-King, John W Salerno, Jane Morley Kotchen, Charles N Alexander.   

Abstract

BACKGROUND: Blacks have disproportionately high rates of cardiovascular disease. Psychosocial stress may contribute to this disparity. Previous trials on stress reduction with the Transcendental Meditation (TM) program have reported improvements in cardiovascular disease risk factors, surrogate end points, and mortality in blacks and other populations. METHODS AND
RESULTS: This was a randomized, controlled trial of 201 black men and women with coronary heart disease who were randomized to the TM program or health education. The primary end point was the composite of all-cause mortality, myocardial infarction, or stroke. Secondary end points included the composite of cardiovascular mortality, revascularizations, and cardiovascular hospitalizations; blood pressure; psychosocial stress factors; and lifestyle behaviors. During an average follow-up of 5.4 years, there was a 48% risk reduction in the primary end point in the TM group (hazard ratio, 0.52; 95% confidence interval, 0.29-0.92; P=0.025). The TM group also showed a 24% risk reduction in the secondary end point (hazard ratio, 0.76; 95% confidence interval, 0.51-0.1.13; P=0.17). There were reductions of 4.9 mmHg in systolic blood pressure (95% confidence interval -8.3 to -1.5 mmHg; P=0.01) and anger expression (P<0.05 for all scales). Adherence was associated with survival.
CONCLUSIONS: A selected mind-body intervention, the TM program, significantly reduced risk for mortality, myocardial infarction, and stroke in coronary heart disease patients. These changes were associated with lower blood pressure and psychosocial stress factors. Therefore, this practice may be clinically useful in the secondary prevention of cardiovascular disease. Clinical Trial Registration- URL: www.clinicaltrials.gov Unique identifier: NCT01299935.

Entities:  

Mesh:

Year:  2012        PMID: 23149426      PMCID: PMC7269100          DOI: 10.1161/CIRCOUTCOMES.112.967406

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  61 in total

1.  Autonomic and EEG patterns during eyes-closed rest and transcendental meditation (TM) practice: the basis for a neural model of TM practice.

Authors:  F Travis; R K Wallace
Journal:  Conscious Cogn       Date:  1999-09

Review 2.  Focused attention, open monitoring and automatic self-transcending: Categories to organize meditations from Vedic, Buddhist and Chinese traditions.

Authors:  Fred Travis; Jonathan Shear
Journal:  Conscious Cogn       Date:  2010-02-18

3.  Beta-adrenergic receptor sensitivity in subjects practicing transcendental meditation.

Authors:  P J Mills; R H Schneider; D Hill; K G Walton; R K Wallace
Journal:  J Psychosom Res       Date:  1990       Impact factor: 3.006

4.  Comparability of mortality follow-up before and after the National Death Index.

Authors:  S A Edlavitch; J Baxter
Journal:  Am J Epidemiol       Date:  1988-06       Impact factor: 4.897

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project.

Authors:  M Friedman; C E Thoresen; J J Gill; D Ulmer; L H Powell; V A Price; B Brown; L Thompson; D D Rabin; W S Breall
Journal:  Am Heart J       Date:  1986-10       Impact factor: 4.749

7.  Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS).

Authors:  P J Elmer; R Grimm; B Laing; G Grandits; K Svendsen; N Van Heel; E Betz; J Raines; M Link; J Stamler
Journal:  Prev Med       Date:  1995-07       Impact factor: 4.018

8.  The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence.

Authors:  Yoichi Chida; Andrew Steptoe
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

9.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.

Authors:  Lisa F Berkman; James Blumenthal; Matthew Burg; Robert M Carney; Diane Catellier; Marie J Cowan; Susan M Czajkowski; Robert DeBusk; James Hosking; Allan Jaffe; Peter G Kaufmann; Pamela Mitchell; James Norman; Lynda H Powell; James M Raczynski; Neil Schneiderman
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  Cross-sectional association between perceived discrimination and hypertension in African-American men and women: the Pitt County Study.

Authors:  Calpurnyia B Roberts; Anissa I Vines; Jay S Kaufman; Sherman A James
Journal:  Am J Epidemiol       Date:  2007-12-13       Impact factor: 4.897

View more
  63 in total

1.  Comment on 'Investigating the effect of the Transcendental Meditation Technique on blood pressure: a systematic review and meta-analysis'.

Authors:  D Orme-Johnson
Journal:  J Hum Hypertens       Date:  2015-11-05       Impact factor: 3.012

2.  Transcendental meditation and blood pressure.

Authors:  S Urushidani; A Kuriyama
Journal:  J Hum Hypertens       Date:  2015-07-09       Impact factor: 3.012

Review 3.  Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease.

Authors:  Dagmara Hering; Kamila Lachowska; Markus Schlaich
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

4.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 5.  Meditation, Health and Scientific Investigations: Review of the Literature.

Authors:  Cynthia Vieira Sanches Sampaio; Manuela Garcia Lima; Ana Marice Ladeia
Journal:  J Relig Health       Date:  2017-04

6.  Mindfulness-Based Stress Reduction and Group Support Decrease Stress in Adolescents with Cardiac Diagnoses: A Randomized Two-Group Study.

Authors:  Vicki A Freedenberg; Pamela S Hinds; Erika Friedmann
Journal:  Pediatr Cardiol       Date:  2017-07-12       Impact factor: 1.655

7.  Yoga--a promising technique to control cardiovascular disease.

Authors:  S C Manchanda
Journal:  Indian Heart J       Date:  2014-10-08

8.  Reducing racial and ethnic disparities in hypertension prevention and control: what will it take to translate research into practice and policy?

Authors:  Michael Mueller; Tanjala S Purnell; George A Mensah; Lisa A Cooper
Journal:  Am J Hypertens       Date:  2014-12-12       Impact factor: 2.689

Review 9.  State of the Art Review: Depression, Stress, Anxiety, and Cardiovascular Disease.

Authors:  Beth E Cohen; Donald Edmondson; Ian M Kronish
Journal:  Am J Hypertens       Date:  2015-04-24       Impact factor: 2.689

Review 10.  Yoga and meditation in cardiovascular disease.

Authors:  S C Manchanda; Kushal Madan
Journal:  Clin Res Cardiol       Date:  2014-01-25       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.